Breast Cancer Treatment: What You Need to Know: What

Breast cancer treatment depends on stage, subtype (hormone receptor, HER2 status), and patient factors such as age and overall health. Options include surgery (lumpectomy or mastectomy), radiation therapy, chemotherapy, hormone therapy, and targeted therapies. Five-year survival for localised disease exceeds 95% in many regions; early detection through mammography and self-examination improves outcomes. Treatment plans are increasingly personalised based on genomic testing and multidisciplinary tumour boards.

Treatment Modalities Explained

Surgery and Radiation

Lumpectomy removes the tumour while preserving the breast; radiation typically follows to reduce local recurrence. Mastectomy removes the entire breast; reconstruction may be immediate or delayed. Sentinel node biopsy assesses lymph node involvement. Radiation targets remaining cancer cells after surgery; regimens vary from three to six weeks. Choice depends on tumour size, location, patient preference, and genetic factors.

Systemic Therapy: Chemo, Hormone, and Targeted

Chemotherapy uses drugs to kill rapidly dividing cells; it may be given before (neoadjuvant) or after (adjuvant) surgery. Hormone therapy—tamoxifen, aromatase inhibitors—blocks oestrogen in hormone-receptor-positive disease. Targeted therapies (e.g., trastuzumab for HER2-positive cancer) attack specific molecular features. Genomic tests (e.g., Oncotype DX) help determine who benefits from chemotherapy.

Support and Survivorship

During Treatment

Patient navigators, support groups, and counselling help manage the emotional and practical challenges of treatment. Financial assistance programmes—from charities, manufacturers, and hospitals—can offset costs. Family and friends provide practical support; clear communication about needs improves outcomes.

Long-Term Care

Survivorship care addresses long-term effects (fatigue, neuropathy, lymphedema), recurrence monitoring, and screening for second cancers. Follow-up schedules vary by stage and treatment. Lifestyle factors—exercise, diet, limiting alcohol—may reduce recurrence risk. Discuss a survivorship care plan with your oncology team.

Screening and Early Detection

Mammography and Risk Assessment

Treatment decisions are made by multidisciplinary teams including surgeons, medical oncologists, radiation oncologists, and pathologists. Second opinions are valuable for major decisions; many patients seek them. Clinical trials may offer access to newer therapies. Fertility preservation options exist for those who wish to have children after treatment. Genetic counselling and testing identify hereditary risk and guide screening for family members. Support organisations provide information, peer support, and practical assistance throughout the journey.

Neoadjuvant therapy—treatment before surgery—can shrink tumours and enable breast-conserving surgery. Response to neoadjuvant treatment provides prognostic information. Reconstruction options include implants and autologous (flap) procedures. Timing of reconstruction—immediate or delayed—depends on need for radiation and patient preference. Lymphedema can occur after lymph node removal; early intervention helps. Physical therapy and exercise support recovery. Mental health support addresses anxiety, depression, and body image concerns. Integrative therapies—acupuncture, massage, mindfulness—may complement conventional treatment; discuss with your oncology team.

Palliative care focuses on quality of life and can be provided alongside curative treatment. Advance care planning ensures your wishes are known. Survivorship care plans document treatment history and follow-up needs. Long-term surveillance includes mammography and clinical exams. Bone density monitoring may be needed for those on hormone therapy. Heart health monitoring is important after certain chemotherapies. Secondary cancers are a concern; screening recommendations may be modified. Support extends beyond treatment; many organisations offer survivorship programmes. Connecting with other survivors reduces isolation. Research advances continue to improve outcomes.

Immunotherapy has joined the treatment arsenal for some breast cancers. Biomarker testing guides therapy selection. Personalised medicine tailors treatment to tumour characteristics. Side effect management has improved with supportive care. Fertility preservation should be discussed before treatment when relevant. Sexual health and intimacy may be affected; resources exist. Financial toxicity is real; assistance programmes help. Workplace accommodations may be needed during treatment. The journey from diagnosis through survivorship is unique to each person. Comprehensive care addresses medical, emotional, and practical needs. Advances in research continue to improve outcomes and quality of life.

Mammography remains the primary screening tool; guidelines vary by age and risk. Women with a family history or genetic mutations (BRCA1/2) may need earlier or more frequent screening, sometimes with MRI. Self-examination raises awareness but is not a substitute for clinical screening. Know your family history and discuss personalised screening with your doctor. Early detection significantly improves outcomes—five-year survival for localised disease exceeds 95% in many regions.

Advances in screening and treatment have improved outcomes significantly. Early detection saves lives. Know your risk factors and discuss screening with your doctor. Treatment is increasingly personalised. Support is available at every stage. You are not alone. Organisations worldwide provide information, support, and advocacy. Research continues to bring new hope. Focus on what you can control: screening, lifestyle, and engagement with your care team. Survivorship is a growing focus. Life after treatment brings new challenges and opportunities. A multidisciplinary approach ensures comprehensive care. Taking the time to research and plan pays dividends. Whether you are just starting or deepening your knowledge, the information in this guide provides a solid foundation for informed decisions. Your care team can help you navigate the many options available.

Advances in treatment continue to improve outcomes. Work closely with your healthcare team to understand your options and make informed decisions.